Discover How the Medable Platform Suits your Needs

Request a personalized demo today and see first hand how Medable's flexible and modular decentralized clinical trial (DCT) platform can scale up or down to suit the unique needs of your TA, indication, and protocol.
Trusted by
Combine these modules and more to build the right DCT for your study
Informed consents with
Medable TeleConsent
Clinical Outcome Assessments with
Medable TeleCOA
Remote visits with
Medable TeleVisit
Medable’s flexible and modular platform means that we can deploy their platform to shift a number of scheduled visits from onsite to remote while still maintaining the patient/investigator relationship that is core to every clinical study.
Dr. Robert Bissonnette, MD, FRCPC, founder and CEO of Innovaderm
Why Medable?
1M
Over 1 million patients on platform
>90%
>90% patient app satisfaction
85+
85+ studies across 41+ countries
10-14w
Accelerated Deployment of 10-14 weeks